USPTO serial 79370271
ORIFARM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 12, 2025
- Examiner
- SULLIVAN, JOHN C
- Law office
- GENERIC WEB UPDATE
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ORIFARM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Meichelle R. MacGregor
Meichelle R. MacGregor Cowan, Liebowitz & Latman, P.C.114 West 47th StreetNew York, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Non-medicated cosmetics and toiletry preparations, perfumery; essential oils; the foregoing excluding dental and other oral health care products | ACTIVE | — |
| 005 | Pharmaceutical preparations and chemical preparations for medical and veterinary purposes, namely, for the treatment of metabolic and digestive conditions, hematopoietic and circulatory conditions, cardiac health conditions, dermatological conditions, urogenital conditions, sex hormonal conditions, systemic hormonal conditions, infectious diseases, antineoplastic and immunomodulatory conditions, musculoskeletal health conditions, neurological conditions, parasitological conditions, respiratory conditions, ocular and auditory health conditions, allergens-related conditions, hyperkalemia, hyperphosphatemia, calcium metabolic imbalances, and in the nature of pharmaceutical and medical preparations containing vitamins, minerals, antidotes, iron chelating agents, and contrast agents for the treatment of the aforementioned conditions; the foregoing excluding dental and other oral health care products | ACTIVE | — |
| 010 | Surgical apparatus and instruments; medical and veterinary apparatus and instruments for surgical use; medical and veterinary apparatus and instruments for therapeutic use, namely, therapeutic equipment and devices for treating respiratory, metabolic and cardiovascular diseases in the nature of colds, coughing, nasal congestion, sore throat, ear congestion, sinus congestion, sinus inflammation, and inflammatory eye diseases; artificial limbs and eyes; orthopedic articles, namely, cushions, supports, padding, bandages, braces, footwear, hosiery, soles, belts, and walkers; suture materials; therapeutic articles and aids adapted for persons with disabilities, namely, compression wraps; massage apparatus; devices and articles for nursing infants, namely, bottles; devices and articles for sexual activity, namely, sex toys; the foregoing excluding dental equipment and other oral health care products | ACTIVE | — |
| 035 | Retail and wholesale store services featuring non-medicated cosmetics and toiletries, perfumery, essential oils, pharmaceutical, medical and veterinary preparations, sanitary preparations for medical purposes, dietetic foods and preparations adapted for medical or veterinary use, foodstuffs for infants, dietary supplements for humans and animals, vitamins and vitamin preparations, medical plasters, medical dressings, surgical, medical, and veterinary apparatus and instruments, artificial limbs and eyes, orthopedic articles, suture materials, therapeutic articles and aids adapted for persons with disabilities, massage apparatus, devices and articles for nursing infants, devices and articles for sexual activity; the foregoing excluding dental equipment and other health care products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Orifarm Generics A/S
- Other trademarks owned by Orifarm Generics A/S
- Other trademarks owned by Orifarm Generics A/S
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Similar marks named ORIFARM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 5, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 18, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 17, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 12, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 12, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 12, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 20, 2025 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jul 8, 2025 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Jul 7, 2025 | APET | ASSIGNED TO PETITION STAFF | — |
| May 12, 2025 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Apr 8, 2025 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 11, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 11, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 5, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 14, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 13, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 13, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 13, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 9, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 23, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 23, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 21, 2024 | RFNP | REFUSAL PROCESSED BY IB | — |
| Aug 14, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 30, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 30, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 30, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 27, 2024 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jan 31, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 19, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 19, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 19, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 18, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 18, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 22, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 30, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 30, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 27, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 26, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 30, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 26, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 25, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |